467 related articles for article (PubMed ID: 27044796)
61. Initial treatment of peritoneal dialysis peritonitis without vancomycin with a once-daily cefazolin-based regimen.
Goldberg L; Clemenger M; Azadian B; Brown EA
Am J Kidney Dis; 2001 Jan; 37(1):49-55. PubMed ID: 11136167
[TBL] [Abstract][Full Text] [Related]
62. Cost-effectiveness of prophylactic nasal mupirocin in patients undergoing peritoneal dialysis based on a randomized, placebo-controlled trial.
Davey P; Craig AM; Hau C; Malek M
J Antimicrob Chemother; 1999 Jan; 43(1):105-12. PubMed ID: 10381107
[TBL] [Abstract][Full Text] [Related]
63. Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes.
Barraclough K; Hawley CM; McDonald SP; Brown FG; Rosman JB; Wiggins KJ; Bannister KM; Johnson DW
Am J Kidney Dis; 2010 Jan; 55(1):121-31. PubMed ID: 19932543
[TBL] [Abstract][Full Text] [Related]
64. Microbiology of peritoneal dialysis-related infection and factors of refractory peritoneal dialysis related peritonitis: A ten-year single-center study in Taiwan.
Wang HH; Huang CH; Kuo MC; Lin SY; Hsu CH; Lee CY; Chiu YW; Chen YH; Lu PL
J Microbiol Immunol Infect; 2019 Oct; 52(5):752-759. PubMed ID: 30665844
[TBL] [Abstract][Full Text] [Related]
65. Insights on peritoneal dialysis-related infections.
Piraino B
Contrib Nephrol; 2009; 163():161-168. PubMed ID: 19494610
[TBL] [Abstract][Full Text] [Related]
66. Dialysis: The importance of peritoneal catheter exit-site care.
Piraino B
Nat Rev Nephrol; 2010 May; 6(5):259-60. PubMed ID: 20424630
[No Abstract] [Full Text] [Related]
67. Peritoneal dialysis infections recommendations.
Piraino B
Contrib Nephrol; 2006; 150():181-186. PubMed ID: 16721009
[TBL] [Abstract][Full Text] [Related]
68. Exit-site care in Austrian peritoneal dialysis centers -- a nationwide survey.
Kopriva-Altfahrt G; König P; Mündle M; Prischl F; Roob JM; Wiesholzer M; Vychytil A; ; Arneitz K; Karner A; Artes R; Wolf E; Auinger M; Pawlak A; Fraberger J; Hofbauer S; Galvan G; Salmhofer H; Pichler B; Wazel M; Gruber M; Thonhofer A; Hager A; Malajner S; Heiss S; Braunsteiner T; Zweiffler M; König P; Rudnicki M; Kogler R; Kohlhauser D; Wiesinger T; Kopriva-Altfahrt G; Moser E; Kotanko P; Loibner H; Nitz H; Miska HJ; Wenzel R; Wölfer M; Mündle M; Breuss H; Hölzl B; Prischi F; Schmekal B; Riener EM; Roob JM; Wonisch W; Vikydal R; Vychytil A; Frank B; Wieser C; Wiesholzer M; Pokorny K
Perit Dial Int; 2009; 29(3):330-9. PubMed ID: 19458307
[TBL] [Abstract][Full Text] [Related]
69. The effects of weekly mupirocin application on infections in continuous ambulatory peritoneal dialysis patients.
Zeybel M; Ozder A; Sanlidag C; Yildiz S; Cavdar C; Ersoy R; Celik A; Camsari T
Adv Perit Dial; 2003; 19():198-201. PubMed ID: 14763062
[TBL] [Abstract][Full Text] [Related]
70. Clinical outcomes in peritoneal dialysis: impact of continuous quality provement initiatives.
Qamar M; Sheth H; Bender FH; Piraino B
Adv Perit Dial; 2009; 25():76-9. PubMed ID: 19886322
[TBL] [Abstract][Full Text] [Related]
71. Current epidemiology and practice patterns in prevention and treatment of PD-related infections in Poland.
Lichodziejewska-Niemierko M; Chmielewski M; Wojtaszek E; Suchowierska E; Gołembiewska E; Grajewska M; Matuszkiewicz-Rowińska J; Naumnik B; Sulikowska B; Niemczyk S; Kłak R; Mosakowska M; Jagodziński P; Marcykiewicz B; Kalita K; Krawczyk R; Cieszyński K; Adamski M; Bronk M
Int Urol Nephrol; 2019 Feb; 51(2):335-341. PubMed ID: 30604230
[TBL] [Abstract][Full Text] [Related]
72. Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients.
Johnson DW; van Eps C; Mudge DW; Wiggins KJ; Armstrong K; Hawley CM; Campbell SB; Isbel NM; Nimmo GR; Gibbs H
J Am Soc Nephrol; 2005 May; 16(5):1456-62. PubMed ID: 15788475
[TBL] [Abstract][Full Text] [Related]
73. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003.
Davenport A
Perit Dial Int; 2009; 29(3):297-302. PubMed ID: 19458302
[TBL] [Abstract][Full Text] [Related]
74. Chlorhexidine-impregnated sponge dressing for prevention of catheter exit-site infection in peritoneal dialysis patients: a pilot study.
Htay H; Choo JCJ; Johnson DW; Pascoe EM; Jayaballa M; Oei EL; Ng LC; Wu SY; Foo MWY
Int Urol Nephrol; 2021 Apr; 53(4):803-812. PubMed ID: 33025409
[TBL] [Abstract][Full Text] [Related]
75. Center Effects and Peritoneal Dialysis Peritonitis Outcomes: Analysis of a National Registry.
Htay H; Cho Y; Pascoe EM; Darssan D; Nadeau-Fredette AC; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW
Am J Kidney Dis; 2018 Jun; 71(6):814-821. PubMed ID: 29289475
[TBL] [Abstract][Full Text] [Related]
76. Atypical mycobacterial exit-site infection and peritonitis in peritoneal dialysis patients on prophylactic exit-site gentamicin cream.
Lo MW; Mak SK; Wong YY; Lo KC; Chan SF; Tong GM; Lo KY; Wong PN; Tse CW; Kam KM; Wong AK
Perit Dial Int; 2013; 33(3):267-72. PubMed ID: 23032088
[TBL] [Abstract][Full Text] [Related]
77. Outcomes of
Htay H; Cho Y; Pascoe EM; Hawley C; Clayton PA; Borlace M; Badve SV; Sud K; Boudville N; McDonald SP; Johnson DW
Perit Dial Int; 2018; 38(4):257-265. PubMed ID: 29437143
[TBL] [Abstract][Full Text] [Related]
78. Treatment for peritoneal dialysis-associated peritonitis.
Ballinger AE; Palmer SC; Wiggins KJ; Craig JC; Johnson DW; Cross NB; Strippoli GF
Cochrane Database Syst Rev; 2014 Apr; (4):CD005284. PubMed ID: 24771351
[TBL] [Abstract][Full Text] [Related]
79. Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients.
Crabtree JH; Hadnott LL; Burchette RJ; Siddiqi RA
Adv Perit Dial; 2000; 16():271-5. PubMed ID: 11045309
[TBL] [Abstract][Full Text] [Related]
80. Outcome and complications in peritoneal dialysis patients: a five-year single center experience.
Alwakeel JS; Alsuwaida A; Askar A; Memon N; Usama S; Alghonaim M; Feraz NA; Shah IH; Wilson H
Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):245-51. PubMed ID: 21422621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
